Nigeria Pharmaceuticals and Healthcare Report Q1 2014:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Book your hotel early for a discount! You can reap the rewards with great discounts at participating Pullman, M Gallery, Grand Mercure, Novotel, Mercure, ibis and Formule 1 hotels. From our sponsors

Nigeria Pharmaceuticals and Healthcare Report Q1 2014 Nov 13th 2013, 00:00, by swapnil BMI View: Medicines demand in Nigeria will be driven by urbanisation, rising per capita incomes, a growing burden on non-communicable diseases and the government’s plans to increase widespread healthcare access to all citizens. However, we note that government spending is significantly dependent on oil and gas revenues and, as such, any fall in prices of these commodities is likely to cause a decline in government investment in healthcare. Key downside risks to foreign multinational investment include low pharmaceutical per capita spending, weak patent respect and poor business transparency. Headline Expenditure Projections ? Pharmaceuticals: NGN174.5bn (US$1.10bn) in 2012 to NGN203.8bn (US$1.28bn) … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=130044. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/nigeria-pharmaceuticals-and-healthcare-report-q1-2014-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions